We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Alemtuzumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Alemtuzumab [PDF, 1.14 MB]

AusPAR: Alemtuzumab [DOCX, 1.9 MB]

Attachment: Product Information: Alemtuzumab [PDF, 410.46 KB]

Attachment: Product Information: Alemtuzumab [DOC, 441.5 KB]

Attachment: Extract from the Clinical Evaluation Report: Alemtuzumab [PDF, 4.95 MB]

Attachment: Extract from the Clinical Evaluation Report: Alemtuzumab [DOCX, 13.03 MB]

Device/Product Name

Lemtrada / Remniq

Active ingredients

Alemtuzumab (rch)

AusPAR Date

4 February 2014

Published

27 February 2014

Submission Number

PM-2012-02297-3-1

Submission Type

New dosage strength, New patient group, New dosage regime

Decision

Approved

Product types

Prescription medicines